Company Overview of AbFrontier Co., Ltd.
AbFrontier Co., Ltd., a biotech company, produces polyclonal and monoclonal antibodies and proteins. It offers ROS signaling, neuroscience, serum protein, cell signaling, and specialized antibodies categories. The company also provides proteome analysis, DNA cloning, protein purification, antibody production, and virus construction services. In addition, it offers antibody manufacturing services. AbFrontier Co., Ltd. is based in Seoul, South Korea. As of April 29, 2008, AbFrontier Co., Ltd. operates as a subsidiary of Young in Frontier Co. Ltd.
11F., Byucksan Digital Valley 5th
82 2 2140 3383
82 2 2140 3320
Key Executives for AbFrontier Co., Ltd.
AbFrontier Co., Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Advanced Protein Technologies Corporation||Asia|
|Aetna Genetech Inc.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact AbFrontier Co., Ltd., please visit www.abfrontier.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.